Combination Therapy of Oral Hypoglycemic Agents in Patients with Type 2 Diabetes Mellitus
Min Kyong Moon (Moon MK), Kyu-Yeon Hur (Hur KY), Seung-Hyun Ko (Ko SH), Seok-O Park (Park SO), Byung-Wan Lee (Lee BW), Jin Hwa Kim (Kim JH), Sang Youl Rhee (Rhee SY), Hyun Jin Kim (Kim HJ), Kyung Mook Choi (Choi KM), Nan-Hee Kim (Kim NH),
Diabetes Metab J. 2017;41(5):357-366.   Published online 2017 Oct 24     DOI:
Citations to this article as recorded by Crossref logo
The Gut Microbiome, Metformin, and Aging
Sri Nitya Reddy Induri, Payalben Kansara, Scott C. Thomas, Fangxi Xu, Deepak Saxena, Xin Li
Annual Review of Pharmacology and Toxicology.2022; 62(1): 85.     CrossRef
Role of resveratrol supplementation in regulation of glucose hemostasis, inflammation and oxidative stress in patients with diabetes mellitus type 2: A randomized, placebo-controlled trial
Wajiha Mahjabeen, Dilshad Ahmed Khan, Shakil Ahmed Mirza
Complementary Therapies in Medicine.2022; 66: 102819.     CrossRef
Increasing Individual Target Glucose Levels to Prevent Hypoglycemia in Patients with Diabetes
Juyoung Shin, Hyunah Kim, Hun-Sung Kim, Churlmin Kim, Whan-Seok Choi
Korean Journal of Family Medicine.2021; 42(4): 269.     CrossRef
Treatment intensification in type 2 diabetes management after the failure of two oral hypoglycemic agents: A nonā€interventional comparative study
Sirajudeen Shaik Alavudeen, Sultan M. Alshahrani, Easwaran Vigneshwaran, Noohu Abdulla Khan, Javid I. Mir, Abubakr T. M. Hussein
International Journal of Clinical Practice.2021;[Epub]     CrossRef
Aldose reductase and protein tyrosine phosphatase 1B inhibitors as a promising therapeutic approach for diabetes mellitus
Antonios Kousaxidis, Anthi Petrou, Vasiliki Lavrentaki, Maria Fesatidou, Ioannis Nicolaou, Athina Geronikaki
European Journal of Medicinal Chemistry.2020; 207: 112742.     CrossRef
Letter: Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2019;43;276-86)
Hannah Seok, Tae Seo Sohn
Diabetes & Metabolism Journal.2019; 43(4): 545.     CrossRef
A Survey of the Structures of US FDA Approved Combination Drugs
Pradipta Das, Michael D. Delost, Munaum H. Qureshi, David T. Smith, Jon T. Njardarson
Journal of Medicinal Chemistry.2019; 62(9): 4265.     CrossRef
Experimental design methodology for optimization and robustness determination in ion pair RP-HPLC method development: Application for the simultaneous determination of metformin hydrochloride, alogliptin benzoate and repaglinide in tablets
Marianne A. Mahrouse, Nesrine T. Lamie
Microchemical Journal.2019; 147: 691.     CrossRef
The influence of diabetes and antidiabetic medications on the risk of pancreatic cancer: a nationwide population-based study in Korea
Da Young Lee, Ji Hee Yu, Sanghyun Park, Kyungdo Han, Nam Hoon Kim, Hye Jin Yoo, Kyung Mook Choi, Sei Hyun Baik, Nan Hee Kim, Ji A. Seo
Scientific Reports.2018;[Epub]     CrossRef
Effect of Lifestyle Modification and Oral Anti-Diabetic Drugs on Metabolic Parameters in Recently Diagnosed Patientswith Uncomplicated Type 2 Diabetes Mellitus in Eastern India
Nikhilesh Pradhan, Sidhartha Das, Anoj Kumar Baliarsinha, Ashirbad Parhi, Bijan Patnaik, Pramod Kumar Rout
Journal of Diabetes Mellitus.2018; 08(02): 9.     CrossRef
Failure of monotherapy in clinical practice in patients with type 2 diabetes: The Korean National Diabetes Program
Ja Young Jeon, Soo Jin Lee, Sieun Lee, Soo Jin Kim, Seung Jin Han, Hae Jin Kim, Dae Jung Kim, Young Seol Kim, Jeong Taek Woo, Kyu Jeung Ahn, Moonsuk Nam, Sei Hyun Baik, Yongsoo Park, Kwan-Woo Lee
Journal of Diabetes Investigation.2018; 9(5): 1144.     CrossRef